FDA Proposes that Interchangeability Status for Biosimilars Doesn’t Need Switching StudiesJune 28, 2024Business of MedicineMixed Topics
Ixekizumab Met Phase 3 Trial Endpoint in Juvenile PsA, Enthesitis-Related ArthritisJune 24, 2024PediatricsMixed Topics
Doctors Endorsing Products on X May Not Disclose Company TiesJune 19, 2024Gene TherapyMixed TopicsBusiness of MedicineLOTME
Follow-Up Outcomes Data Often Missing for FDA Drug Approvals Based on Surrogate MarkersMay 20, 2024Business of MedicineMixed Topics
Chatbots Seem More Empathetic Than Docs in Cancer DiscussionsMay 16, 2024Mixed TopicsPediatricsBusiness of Medicine
Are Direct-to-Consumer Microbiome Tests Clinically Useful?April 25, 2024Business of MedicineMixed Topics
No Increase in Autoimmune Risk Seen With GLP-1 Receptor Agonists and SGLT2 InhibitorsMarch 7, 2024Mixed Topics
Use of Biologics for Psoriasis Found to Confer a Survival BenefitFebruary 23, 2024Psoriatic ArthritisMixed Topics
Mixing Paxlovid With Specific Immunosuppressants Risks Serious Adverse ReactionsFebruary 14, 2024COVID-19 UpdatesMixed TopicsLupus & Connective Tissue Diseases
